{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:44:22Z","timestamp":1784360662337,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003456.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000}}],"reference-count":143,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003456.pub3","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T10:02:45Z","timestamp":1497952965000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug therapy for chronic idiopathic axonal polyneuropathy"],"prefix":"10.1002","volume":"2017","author":[{"given":"Janna","family":"Warendorf","sequence":"first","affiliation":[{"name":"Brain Center Rudolf Magnus, University Medical Center Utrecht; Department of Neurology; Heidelberglaan 100 Utrecht Netherlands 3584 CX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander FJE","family":"Vrancken","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, Brain Center Rudolf Magnus; Department of Neurology; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo N","family":"van Schaik","sequence":"additional","affiliation":[{"name":"Academic Medical Centre, University of Amsterdam; Department of Neurology; Meibergdreef 9 PO Box 22700 Amsterdam Netherlands 1100 DE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; MRC Centre for Neuromuscular Diseases; PO Box 114 Queen Square London UK WC1N 3BG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette C","family":"Notermans","sequence":"additional","affiliation":[{"name":"Brain Center Rudolf Magnus, University Medical Center Utrecht; Department of Neurology; Heidelberglaan 100 Utrecht Netherlands 3584 CX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1212\/WNL.38.11.1731","article-title":"Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia","volume":"38","author":"Bradley","year":"1988","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00044011-199510060-00001","article-title":"L-acetylcarnitine in the treatment of patients with peripheral neuropathies: a short term, double-blind clinical study of 426 patients","volume":"10","author":"Grandis","year":"1995","journal-title":"Clinical Drug Investigation"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"issue":"7637","key":"10.1002\/14651858.CD003456.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.39429.619653.80","article-title":"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study","volume":"336","author":"Frank","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/WNL.55.7.971","article-title":"Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions","volume":"55","author":"Galer","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AJP.0b013e3181fe13f6","article-title":"Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial","volume":"27","author":"Gilron","year":"2011","journal-title":"Clinical Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ejp.731","article-title":"Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain","volume":"20","author":"Haanp\u00e4\u00e4","year":"2016","journal-title":"European Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pain.2010.10.050","article-title":"Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain","volume":"152","author":"Hewitt","year":"2011","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/AJP.0b013e318156db26","article-title":"Topical amitriptyline versus lidocaine in the treatment of neuropathic pain","volume":"24","author":"Ho","year":"2008","journal-title":"The Clinical Journal of Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD003456.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pain.2008.07.013","article-title":"Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies","volume":"141","author":"Ho","year":"2009","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ejpain.2010.11.007","article-title":"The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial","volume":"15","author":"Holbech","year":"2011","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/j.pain.0000000000000143","article-title":"Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial","volume":"156","author":"Holbech","year":"2015","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejpain.2009.08.002","article-title":"Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain","volume":"14","author":"Huge","year":"2010","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0015|cit15","first-page":"714","article-title":"Behandlung von Polyneuropathien. Untersuchungen zur Wirksamkeit von Ginkgo-biloba-Extrakt EGb 761 bei Patienten mit Polyneuropathie","volume":"69","author":"Husstedt","year":"1993","journal-title":"Zeitschrift f\u00fcr Allgemeine Medizin"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/AJP.0b013e31823f9e64","article-title":"The pain quality response profile of pregabalin in the treatment of neuropathic pain","volume":"28","author":"Jensen","year":"2012","journal-title":"Clinical Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3959(89)90134-6","article-title":"Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain","volume":"37","author":"Kishore-Kumar","year":"1989","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000115497","article-title":"An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies","volume":"21","author":"Langohr","year":"1982","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6882-10-22","article-title":"The effect of Neuragen PN on neuropathic pain: a randomized, double blind, placebo controlled clinical trial","volume":"10","author":"Li","year":"2010","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(94)00261-C","article-title":"Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy","volume":"62","author":"Low","year":"1995","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(02)00020-9","article-title":"Morphine responsiveness, efficacy and tolerability in patients with chronic no-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS)","volume":"97","author":"Maier","year":"2002","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD003456.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0269216303pm815oa","article-title":"Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial","volume":"17","author":"Morley","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0024|cit24","unstructured":"NCT00156689 A study to determine if levetiracetam will assist those suffering from chronic idiopathic axonal polyneuropathy clinicaltrials.gov\/ct2\/show\/NCT00156689"},{"issue":"1-3","key":"10.1002\/14651858.CD003456.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0026|cit26","first-page":"9","article-title":"L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain","volume":"15","author":"Onofrj","year":"1995","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.62.2.285","article-title":"Valproic acid has no effect in polyneuropathy. A randomized, controlled trial","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pain.2008.04.012","article-title":"Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial","volume":"139","author":"Otto","year":"2008","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.pain.2013.12.016","article-title":"A randomized, double-blind, double-dummy comparison of short- and long-acting dihydrocodeine in chronic non-malignant pain","volume":"155","author":"Pedersen","year":"2014","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13760-014-0395-7","article-title":"Capsaicin 8% as a cutaneous patch (Qutenza\u2122): analgesic effect on patients with peripheral neuropathic pain","volume":"115","author":"Raber","year":"2015","journal-title":"Acta Neurological Belgica"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"Journal of Pain and Symptom Management"},{"issue":"13","key":"10.1002\/14651858.CD003456.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.57.9.1583","article-title":"Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain","volume":"57","author":"Semenchuk","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","article-title":"A double-blind, randomized, placebo-controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment","volume":"18","author":"Serpell","year":"2014","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/cp.1999.v66.103171001","article-title":"The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels","volume":"66","author":"Sindrup","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0304-3959(00)00457-7","article-title":"St. John's wort has no effect on pain in polyneuropathy","volume":"91","author":"Sindrup","year":"2001","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful polyneuropathy","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/j.1532-2149.2011.00069.x","article-title":"Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy","volume":"16","author":"Sindrup","year":"2012","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00002508-199712000-00009","article-title":"A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics","volume":"13","author":"Vrethem","year":"1997","journal-title":"Clinical Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0041|cit41","first-page":"459","article-title":"Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study","volume":"25","author":"Wallace","year":"2000","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jpai.2002.123650","article-title":"A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain","volume":"3","author":"Wallace","year":"2002","journal-title":"Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1085-9489.2004.09311.x","article-title":"Role of insulin-like growth factor-I in the treatment of painful small fiber predominant neuropathy","volume":"9","author":"Windebank","year":"2004","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0045|cit45","unstructured":"NCT02260388 Patient assisted intervention for neuropathy: comparison of treatment in real life situations (PAIN-CONTRoLS) clinicaltrials.gov\/ct2\/show\/NCT02260388"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0046|cit46","unstructured":"Efficacy and safety of lidocaine infusion treatment in management of neuropathic pain: randomized, controlled, comparative study clinicaltrials.gov\/ct2\/show\/NCT02597257"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004573.pub3","article-title":"Vitamin B for treating peripheral neuropathy","author":"Ang","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.j.pain.0000460358.01998.15","article-title":"Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?","volume":"156 Suppl 1","author":"Attal","year":"2015","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10072-012-1167-x","article-title":"Vascular factors predict polyneuropathy in a non-diabetic elderly population","volume":"34","author":"Baldereschi","year":"2013","journal-title":"Neurological Sciences"},{"issue":"8A","key":"10.1002\/14651858.CD003456.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"6C","DOI":"10.1016\/j.amjcard.2005.12.006","article-title":"Statin safety: an overview and assessment of the data--2005","volume":"97","author":"Bays","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpain.2014.06.012","article-title":"Statins: do they aggravate or ameliorate neuropathic pain?","volume":"15","author":"Bhalla","year":"2014","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archneur.55.7.981","article-title":"Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients","volume":"55","author":"Camerlingo","year":"1998","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpain.2005.09.004","article-title":"Economic evaluation of oral treatments for neuropathic pain","volume":"7","author":"Cepeda","year":"2006","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003345.pub2","article-title":"Systemic administration of local anesthetic agents to relieve neuropathic pain","author":"Challapalli","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","author":"Chaparro","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/brain\/119.4.1091","article-title":"Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients","volume":"119","author":"Chia","year":"1996","journal-title":"Brain"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0960-8966(99)00094-2","article-title":"Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy","volume":"10","author":"Deprez","year":"2000","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub3","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011789","article-title":"Milnacipran for neuropathic pain in adults","author":"Derry","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003726.pub3","article-title":"Tramadol for neuropathic pain","author":"Duehmke","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.410100304","article-title":"Intensive evaluation of referred unclassified neuropathies yields improved diagnosis","volume":"10","author":"Dyck","year":"1981","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0033-0620(03)80004-X","article-title":"Cigarette smoking and diabetes","volume":"45","author":"Eliasson","year":"2003","journal-title":"Progression in Cardiovascular Disease"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000315037","article-title":"Pain in patients with chronic idiopathic axonal polyneuropathy","volume":"64","author":"Erdmann","year":"2010","journal-title":"European Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/mus.24969","article-title":"Causes of neuropathy in patients referred as \"idiopathic neuropathy\"","volume":"53","author":"Farhad","year":"2016","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"1997","journal-title":"Diabetes"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00401-002-0669-7","article-title":"Selective decrease in axonal nerve growth factor and insulin-like growth factor I immunoreactivity in axonopathies of unknown etiology","volume":"105","author":"Fressinaud","year":"2003","journal-title":"Acta Neuropathologica (Berlin)"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/jnnp.69.4.442","article-title":"Prospective study of the usefulness of sural nerve biopsy","volume":"69","author":"Gabriel","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1517\/14728214.2014.915025","article-title":"Emerging drugs for neuropathic pain","volume":"19","author":"Gilron","year":"2014","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the overall neuropathy limitations scale","volume":"77","author":"Graham","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jnnp.2005.081497","article-title":"Clinimetric properties of a walking scale in peripheral neuropathy","volume":"77","author":"Graham","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.1991.tb04942.x","article-title":"Cryptogenetic polyneuropathies: an out-patient follow-up study","volume":"84","author":"Grahmann","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0076|cit76","first-page":"401","article-title":"Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study","volume":"7","author":"Hernandez-Ojeda","year":"2014","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0077|cit77","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"Pt 8","key":"10.1002\/14651858.CD003456.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awh192","article-title":"A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy","volume":"127","author":"Hughes","year":"2004","journal-title":"Brain"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1196\/annals.1344.043","article-title":"Neuroprotection in the PNS: erythropoietin and immunophilin ligands","volume":"1053","author":"H\u00f6ke","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0080|cit80","first-page":"69","article-title":"Peripheral neuropathy in chronic respiratory insufficiency","volume":"3","author":"Jann","year":"1998","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/mus.1132","article-title":"Prospective follow-up study of chronic polyneuropathy of undetermined cause","volume":"24","author":"Jann","year":"2001","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/187152710793237412","article-title":"Schwann cells as a therapeutic target for peripheral neuropathies","volume":"9","author":"Lehmann","year":"2010","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1085-9489.2004.09105.x","article-title":"The role of growth factors in diabetic peripheral neuropathy","volume":"9","author":"Leinninger","year":"2004","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1085-9489.2005.10106.x","article-title":"Cryptogenic polyneuropathy: clinical and neurophysiological findings","volume":"10","author":"Lindh","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/09638288.2010.505996","article-title":"Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population","volume":"33","author":"Lindh","year":"2011","journal-title":"Disability and Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/brb3.26","article-title":"Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case-control study","volume":"1","author":"Lindh","year":"2011","journal-title":"Brain and Behavior"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mus.880170908","article-title":"Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy","volume":"17","author":"Logigian","year":"1994","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853890008995903","article-title":"Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?","volume":"32","author":"Malik","year":"2000","journal-title":"Annals of Medicine"},{"issue":"15 Supplement 1","key":"10.1002\/14651858.CD003456.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jpain.2005.09.008","article-title":"Ion channel targets and treatment efficacy in neuropathic pain","volume":"7","author":"Markman","year":"2006","journal-title":"Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.47.5.530","article-title":"Chronic polyneuropathy of undetermined cause","volume":"47","author":"McLeod","year":"1984","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006146.pub2","article-title":"Opioids for neuropathic pain","author":"McNicol","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nmd.2005.12.003","article-title":"131st ENMC International workshop: selection of outcome measures for peripheral neuropathy clinical trials, 10-12 December, Naarden, The Netherlands","volume":"16","author":"Merkies","year":"2006","journal-title":"Neuromuscular Disorders"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011606","article-title":"Antidepressant drugs for neuropathic pain - an overview of Cochrane reviews","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011241.pub2","article-title":"Zonisamide for neuropathic pain in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003456.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010902.pub2","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","article-title":"Rho kinase, a promising drug target for neurological disorders","volume":"4","author":"M\u00fcller","year":"2005","journal-title":"Nature Reviews Drug Discovery"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1468-1331.2008.02197.x","article-title":"Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series","volume":"15","author":"Nebuchennykh","year":"2008","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jnnp.56.10.1066","article-title":"Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients","volume":"56","author":"Notermans","year":"1993","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.57.12.1525","article-title":"Chronic idiopathic axonal polyneuropathy: a five year follow up","volume":"57","author":"Notermans","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6673-8-21","article-title":"Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish population","volume":"8","author":"Persson","year":"2013","journal-title":"Journal of Occupational Medicine and Toxicology"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0103|cit103","first-page":"389","article-title":"Peripheral neuropathy associated with chronic obstructive pulmonary disease","volume":"12","author":"Poza","year":"1997","journal-title":"Neurolog\u00eda"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0104|cit104","first-page":"147","article-title":"Treatment of peripheral neuropathies with neurotrophic factors: animal models and clinical trials","volume":"159","author":"Pradat","year":"2003","journal-title":"Revue Neurologique"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2010.01425.x","article-title":"Neuropathy and impaired glucose tolerance: an updated review of the evidence","volume":"124","author":"Rajabally","year":"2011","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00415-011-5950-z","article-title":"Dyslipidaemia in chronic acquired distal axonal polyneuropathy","volume":"258","author":"Rajabally","year":"2011","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60: II. Prognosis","volume":"2","author":"Rankin","year":"1957","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0108|cit108","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.3.5 2014"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.brainresrev.2007.04.010","article-title":"Neuroactive steroids and peripheral neuropathy","volume":"57","author":"Roglio","year":"2008","journal-title":"Brain Research Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00415-004-0499-8","article-title":"Chronic idiopathic axonal polyneuropathy revisited","volume":"251","author":"Rosenberg","year":"2004","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrd1107","article-title":"Neurotrophic factors as novel therapeutics for neuropathic pain","volume":"2","author":"Sah","year":"2003","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Archives of Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003456.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1529-8027.2012.00395.x","article-title":"Idiopathic neuropathy: new paradigms, new promise","volume":"17","author":"Singer","year":"2012","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"issue":"1-2","key":"10.1002\/14651858.CD003456.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.06.005","article-title":"Idiopathic neuropathy patients are at high risk for metabolic syndrome","volume":"273","author":"Smith","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bja\/aet206","article-title":"Neuropathic pain: a pathway for care developed by the British Pain Society","volume":"111","author":"Smith","year":"2013","journal-title":"British Journal of Anaesthesia"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s40279-014-0207-5","article-title":"Exercise intervention studies in patients with peripheral neuropathy: a systematic review (Provisional abstract)","volume":"44","author":"Streckmann","year":"2014","journal-title":"Sports Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004150050562","article-title":"Quality of life in patients with axonal polyneuropathy","volume":"247","author":"Teunissen","year":"2000","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000008185","article-title":"Relationship between ischemia and neuropathy","volume":"44","author":"Teunissen","year":"2000","journal-title":"European Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010000193","article-title":"Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy","volume":"100","author":"Teunissen","year":"2000","journal-title":"Acta Neuropathologica (Berlin)"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.72.5.590","article-title":"Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?","volume":"72","author":"Teunissen","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jcpt.12297","article-title":"Systematic review of topical amitriptyline for the treatment of neuropathic pain","volume":"40","author":"Thompson","year":"2015","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/1753-0407.12013","article-title":"Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older","volume":"5","author":"Tierney","year":"2013","journal-title":"Journal of Diabetes"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000092405","article-title":"Occupational determinants of cryptogenic polyneuropathy","volume":"26","author":"Tondel","year":"2006","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mus.1171","article-title":"Peripheral neuropathy in young-old and old-old patients","volume":"24","author":"Verghese","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"11-2","key":"10.1002\/14651858.CD003456.pub3-BIB0127|cit127","first-page":"129","article-title":"Idiopathic polyneuropathy. A prospective study including gastrointestinal investigation","volume":"37","author":"Vilming","year":"1987","journal-title":"Journal of Oslo City Hospital"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2337\/dc12-0469","article-title":"Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome","volume":"36","author":"Visser","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jns5.12063","article-title":"Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study","volume":"19","author":"Visser","year":"2014","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0000000000001160","article-title":"Incidence of polyneuropathy in Utrecht, the Netherlands","volume":"84","author":"Visser","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archneur.59.4.533","article-title":"Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people","volume":"59","author":"Vrancken","year":"2002","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00415-004-0275-9","article-title":"Progressive idiopathic axonal neuropathy: a comparative clinical and histopathological study with vasculitic neuropathy","volume":"251","author":"Vrancken","year":"2004","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub3-BIB0133|cit133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003904.pub2","article-title":"Exercise for people with peripheral neuropathy","author":"White","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD003456.pub3-BIB0134|cit134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008146.pub2","article-title":"Interventions for fatigue in peripheral neuropathy","author":"White","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub3-BIB0135|cit135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub3-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010943.pub2","article-title":"Levetiracetam for neuropathic pain in adults","author":"Wiffen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0137|cit137","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011603.pub2","article-title":"Buprenorphine for neuropathic pain in adults","author":"Wiffen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.56.5.540","article-title":"Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics","volume":"56","author":"Wolfe","year":"1999","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub3-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010967.pub2","article-title":"Topical clonidine for neuropathic pain","author":"Wrzosek","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dc11-0503","article-title":"Efficacy and safety of antioxidant treatment with \u03b1-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial","volume":"34","author":"Ziegler","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub3-BIB0141|cit141","first-page":"255","article-title":"Nitric oxide in damage, disease and repair of the peripheral nervous system","volume":"51","author":"Zochodne","year":"2005","journal-title":"Cellular & Molecular Biology"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub3-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003456","article-title":"Drug therapy for chronic idiopathic axonal polyneuropathy","author":"Vrancken","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub3-BIB0143|cit143","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003456.pub2","article-title":"Drug therapy for chronic idiopathic axonal polyneuropathy","author":"Vrancken","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003456.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T09:14:06Z","timestamp":1679303646000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003456.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":143,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003456.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]}}}